DBV Technologies | DBVT - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
Acadia Pharmaceuticals USD 44.57M 32.32M 2026-06
Alnylam Pharmaceuticals USD 108.02M 18.61M 2026-06
Amarin USD 18.8M 29.36M 2026-06
BioCryst Pharmaceuticals USD 11.46M 501K 2026-06
BioMarin Pharmaceutical USD 913.67M 120.52M 2026-06
DBV Technologies USD 39.5M 1.44M 2026-03
Galectin Therapeutics USD 3.7M 99K 2024-06
Halozyme Therapeutics USD 23.61M 9.51M 2026-06
Incyte USD 1.39B 1.16B 2026-06
Insmed USD 74.55M 1.18M 2026-06
Ionis Pharmaceuticals USD 47.7M 21.67M 2026-06
Neurocrine Biosciences USD 691.3M 145.8M 2026-03
PTC Therapeutics USD 40.45M 14.96M 2026-06
Sarepta Therapeutics USD 50.98M 19.39M 2026-06
Ultragenyx Pharmaceutical USD 39M 3M 2026-06
United Therapeutics USD 497.8M 500K 2026-06